UPDATED Jun 28, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A179900 | ₩30,050.00 | 0.2% | 55.7% | ₩475.4b | ₩60,000.00 | PS23.7x | E122.7% | 0% | Tech | ||
300181 | CN¥15.02 | -3.0% | 23.0% | CN¥10.5b | n/a | PE24.6x | E22.3% | 3.0% | Pharmaceuticals & Biotech | ||
SDR | AU$5.09 | -0.8% | 74.3% | AU$1.4b | AU$6.46 | PS8.2x | E75.1% | n/a | Software | ||
4480 | JP¥3,600.00 | 0.1% | -32.6% | JP¥116.8b | JP¥5,800.00 | PE43.7x | E28.7% | n/a | Healthcare | ||
CTT | AU$1.17 | -47.8% | -62.4% | AU$478.2m | AU$3.12 | PE23x | E26.7% | n/a | Retail | ||
A067310 | ₩20,500.00 | -7.2% | -6.2% | ₩972.2b | ₩31,666.67 | PB3.3x | E94.1% | 0.2% | Semiconductors | ||
HHR | AU$0.006 | -14.3% | -76.9% | AU$16.9m | n/a | PE5.7x | E86.3% | n/a | Energy | ||
688408 | CN¥92.08 | -9.7% | 9.2% | CN¥12.4b | CN¥89.23 | PE27x | E25.8% | 1.0% | Capital Goods | ||
A441270 | ₩9,070.00 | 3.1% | 2.1% | ₩335.3b | ₩11,500.00 | PE21.6x | E36.4% | n/a | Tech | ||
PLT | AU$0.79 | -1.3% | 110.7% | AU$138.5m | AU$1.30 | PS1.9x | E106.4% | n/a | Diversified Financials | ||
ACI | ₹669.00 | -4.0% | 24.8% | ₹82.6b | ₹757.20 | PE25.9x | E28.9% | 0.4% | Materials | ||
517522 | ₹589.60 | 0.3% | -29.4% | ₹29.9b | ₹772.00 | PE41.7x | E33.5% | 0.3% | Materials | ||
A204620 | ₩3,650.00 | -5.8% | -6.9% | ₩207.3b | ₩7,100.00 | PS1.9x | E72.4% | n/a | Commercial Services | ||
A178320 | ₩30,700.00 | 8.5% | 56.9% | ₩1.7t | ₩36,666.67 | PE158.9x | E48.1% | 0% | Tech | ||
CRDO | US$31.94 | 16.2% | 84.2% | US$5.2b | US$29.42 | PS27.3x | E60.9% | n/a | Semiconductors | ||
CALTX | SEK 205.60 | 0.4% | 137.1% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
VOW | NOK 6.89 | 18.8% | -47.1% | NOK 784.4m | NOK 11.00 | PB2x | E97.6% | 0% | Commercial Services | ||
KEBNI B | SEK 1.61 | -3.6% | 27.8% | SEK 436.6m | SEK 2.20 | PS4.7x | E90.4% | n/a | Tech | ||
ADOC | €7.80 | 2.2% | 97.0% | €114.9m | €9.70 | PS19x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
GIG | NOK 29.50 | 9.9% | 19.4% | NOK 4.0b | NOK 45.03 | PE18.9x | E36.9% | n/a | Consumer Services | ||
OSE | €5.46 | -8.1% | 65.5% | €118.8m | €7.15 | PS53.3x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
EH | US$13.58 | -5.4% | -10.5% | US$860.1m | US$24.98 | PS39.8x | E74.3% | n/a | Capital Goods | ||
3680 | NT$446.50 | 4.9% | 4.2% | NT$42.1b | NT$509.00 | PE53.9x | E37.2% | 1.7% | Semiconductors | ||
A089030 | ₩63,800.00 | 24.6% | 665.0% | ₩2.3t | ₩49,500.00 | PS15.7x | E118.2% | 0.2% | Semiconductors |